Yasutaka Noda
Papers
1
Total Citations
3
H-Index
1
About
Yasutaka Noda is a leading urologic oncologist whose research focuses on optimizing treatment strategies for high-risk prostate cancer, with a particular emphasis on comparing surgical and radiation-based approaches. His seminal 2024 study directly compared oncological outcomes and health-related quality of life (HRQOL) between robot-assisted radical prostatectomy (RARP) and a combined regimen of high-dose-rate brachytherapy, external beam radiation therapy, and hormone therapy (HDR+). This work, already garnering 3 citations shortly after publication, provides critical evidence for shared decision-making in high-risk prostate cancer management. Noda’s research addresses the pressing clinical question of how to balance cancer control with post-treatment quality of life—a key concern for patients facing aggressive therapy. By systematically evaluating both survival endpoints and patient-reported HRQOL measures, his work helps clinicians and patients weigh the trade-offs between surgical and multimodal radiation approaches. His contributions are particularly valuable in an era of increasingly personalized cancer care, where treatment selection must account for both oncologic efficacy and functional outcomes. Noda continues to advance the field through rigorous comparative effectiveness research that directly informs clinical practice.
Research Focus
Key Achievements
Top Papers
- 1